157 related articles for article (PubMed ID: 6795229)
1. Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs.
Pennington JE; Hickey WF; Blackwood LL; Arnaut MA
J Clin Invest; 1981 Nov; 68(5):1140-8. PubMed ID: 6795229
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide pseudomonas vaccine: efficacy against pulmonary infection with Pseudomonas aeruginosa.
Pennington JE
J Infect Dis; 1979 Jul; 140(1):73-80. PubMed ID: 110888
[TBL] [Abstract][Full Text] [Related]
3. Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia.
Pennington JE; Pier GB; Sadoff JC; Small GJ
Rev Infect Dis; 1986; 8 Suppl 4():S426-33. PubMed ID: 2944209
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of cell wall Pseudomonas aeruginosa vaccines for protection against experimental pneumonia.
Pennington JE; Pier GB
Rev Infect Dis; 1983; 5 Suppl 5():S852-7. PubMed ID: 6419311
[TBL] [Abstract][Full Text] [Related]
5. Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
Gomi R; Sharma A; Wu W; Sung B; Worgall S
Vaccine; 2017 Dec; 35(51):7174-7180. PubMed ID: 29126807
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
8. Influence of mucoid coating on clearance of Pseudomonas aeruginosa from lungs.
Blackwood LL; Pennington JE
Infect Immun; 1981 May; 32(2):443-8. PubMed ID: 6788696
[TBL] [Abstract][Full Text] [Related]
9. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
Zaidi TS; Priebe GP; Pier GB
Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
[TBL] [Abstract][Full Text] [Related]
10. Host defense mechanisms against pneumonia due to Pseudomonas aeruginosa.
Pennington JE; Ehrie MG; Hickey WF
Rev Infect Dis; 1984; 6 Suppl 3():S657-66. PubMed ID: 6443767
[TBL] [Abstract][Full Text] [Related]
11. Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization.
Lange KH; Hougen HP; Høiby N; Fomsgaard A; Rygaard J; Johansen HK
APMIS; 1995 May; 103(5):367-74. PubMed ID: 7654361
[TBL] [Abstract][Full Text] [Related]
12. Impact of molecular biology on Pseudomonas aeruginosa immunization.
Pennington JE
J Hosp Infect; 1988 Feb; 11 Suppl A():96-102. PubMed ID: 2896754
[TBL] [Abstract][Full Text] [Related]
13. Human IgG antibodies to Pseudomonas aeruginosa core lipopolysaccharide determinants are detected in chronic but not acute pseudomonas infection.
Jacobson MA; Radolf JD; Young LS
Scand J Infect Dis; 1987; 19(6):649-60. PubMed ID: 3126549
[TBL] [Abstract][Full Text] [Related]
14. Protection against fatal Pseudomonas aeruginosa sepsis by immunization with smooth and rough lipopolysaccharides.
Cryz SJ; Meadow PM; Fürer E; Germanier R
Eur J Clin Microbiol; 1985 Apr; 4(2):180-5. PubMed ID: 3924605
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a new polyvalent Pseudomonas vaccine in respiratory infections.
Pennington JE; Miler JJ
Infect Immun; 1979 Sep; 25(3):1029-34. PubMed ID: 115786
[TBL] [Abstract][Full Text] [Related]
16. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.
Priebe GP; Walsh RL; Cederroth TA; Kamei A; Coutinho-Sledge YS; Goldberg JB; Pier GB
J Immunol; 2008 Oct; 181(7):4965-75. PubMed ID: 18802100
[TBL] [Abstract][Full Text] [Related]
17. Studies on the ability of alginate to act as a protective immunogen against infection with Pseudomonas aeruginosa in animals.
Woods DE; Bryan LE
J Infect Dis; 1985 Apr; 151(4):581-8. PubMed ID: 3919114
[TBL] [Abstract][Full Text] [Related]
18. Active and passive immunity against Pseudomonas aeruginosa with a ribosomal vaccine and antiserum in C3H/HeJ mice.
Lieberman MM; Ayala E
J Immunol; 1983 Jul; 131(1):1-3. PubMed ID: 6408166
[No Abstract] [Full Text] [Related]
19. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of a nontoxic polysaccharide-protein conjugate that induces active immunity and passively protective antibody against Pseudomonas aeruginosa immunotype 1 in mice.
Tsay GC; Collins MS
Infect Immun; 1984 Jul; 45(1):217-21. PubMed ID: 6429046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
